Looking to the future of organ-on-chip and toxicity assessment: a regulator's opinion

被引：3
|
作者：
Jones, David R. [1 ]
机构：
[1] Prod Regulatory Agcy, Med & Healthcare, 151 Buckingham Palace Rd, London SW1W 9SZ, England
来源：
FUTURE SCIENCE OA | 2016年 / 2卷 / 04期
关键词：
organ-on-chip; pharmacology; regulation; toxicology;
D O I：
10.4155/fsoa-2016-0068
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
David R Jones talks to Francesca Lake, Managing Editor: David R Jones is an Expert Pharmaco-Toxicologist within the Licensing Division of the Medicines and Healthcare products Regulatory Agency. We met him at the Organ-on-a-chip Europe 2016 conference in Cambridge (UK), where he presented 'A UK Regulatory View on the Acceptability of Organ on a Chip Data'.
引用
收藏
页数：3
相关论文
共 27 条
  • [21] Organ-On-A-Chip: Development and Clinical Prospects Toward Toxicity Assessment with an Emphasis on Bone Marrow
    Kim, Jeehye
    Lee, Hanna
    Selimovic, Seila
    Gauvin, Robert
    Bae, Hojae
    DRUG SAFETY, 2015, 38 (05) : 409 - 418
  • [22] Organ-On-A-Chip: Development and Clinical Prospects Toward Toxicity Assessment with an Emphasis on Bone Marrow
    Jeehye Kim
    Hanna Lee
    Šeila Selimović
    Robert Gauvin
    Hojae Bae
    Drug Safety, 2015, 38 : 409 - 418
  • [23] Human-Based New Approach Methodologies in Developmental Toxicity Testing: A Step Ahead from the State of the Art with a Feto-Placental Organ-on-Chip Platform
    Luconi, Michaela
    Sogorb, Miguel A.
    Markert, Udo R.
    Benfenati, Emilio
    May, Tobias
    Wolbank, Susanne
    Roncaglioni, Alessandra
    Schmidt, Astrid
    Straccia, Marco
    Tait, Sabrina
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (23)
  • [24] Steady-state monitoring of oxygen in a high-throughput organ-on-chip platform enables rapid and non-invasive assessment of drug-induced nephrotoxicity
    Kann, Samuel H.
    Shaughnessey, Erin M.
    Zhang, Xin
    Charest, Joseph L.
    Vedula, Else M.
    ANALYST, 2023, 148 (14) : 3204 - 3216
  • [25] The Future of Population-Based Postmarket Drug Risk Assessment: A Regulator's Perspective
    Hammad, T. A.
    Neyarapally, G. A.
    Iyasu, S.
    Staffa, J. A.
    Dal Pan, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (03) : 349 - 358
  • [26] In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities
    Bassan, Arianna
    Alves, Vinicius M.
    Amberg, Alexander
    Anger, Lennart T.
    Beilke, Lisa
    Bender, Andreas
    Bernal, Autumn
    Cronin, Mark T. D.
    Hsieh, Jui-Hua
    Johnson, Candice
    Kemper, Raymond
    Mumtaz, Moiz
    Neilson, Louise
    Pavan, Manuela
    Pointon, Amy
    Pletz, Julia
    Ruiz, Patricia
    Russo, Daniel P.
    Sabnis, Yogesh
    Sandhu, Reena
    Schaefer, Markus
    Stavitskaya, Lidiya
    Szabo, David T.
    Valentin, Jean-Pierre
    Woolley, David
    Zwickl, Craig
    Myatt, Glenn J.
    COMPUTATIONAL TOXICOLOGY, 2021, 20
  • [27] The Evolution of In Vitro Toxicity Assessment Methods for Oral Cavity Tissues-From 2D Cell Cultures to Organ-on-a-Chip
    Jitareanu, Alexandra
    Agoroaei, Luminita
    Caba, Ioana-Cezara
    Cojocaru, Florina-Daniela
    Verestiuc, Liliana
    Vieriu, Madalina
    Martu, Ioana
    TOXICS, 2025, 13 (03)
123